You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

JX-594

Showing 1 - 25 of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumors, Soft-tissue Sarcoma, Breast Cancer Trial in Bordeaux (Cyclophosphamide and JX-594 dose escalation,

Recruiting
  • Solid Tumors
  • +2 more
  • Cyclophosphamide and JX-594 dose escalation
  • +3 more
  • Bordeaux, France
    Institut Bergonie
Feb 1, 2022

Metastatic Tumor, Advanced Tumor Trial in France (Pexa-Vec, Ipilimumab)

Completed
  • Metastatic Tumor
  • Advanced Tumor
  • Bordeaux, France
  • +4 more
Jul 22, 2022

Hepatocellular Carinoma Trial in Korea, Republic of, Spain, United States (JX-594 recombinant vaccina GM-CSF)

Completed
Has Results
  • Hepatocellular Carinoma
  • JX-594 recombinant vaccina GM-CSF
  • Scottsdale, Arizona
  • +4 more
Dec 29, 2020

Colorectal Carcinoma, CRC Trial in Canada, France, United States (JX-594, Irinotecan)

Completed
Has Results
  • Colorectal Carcinoma
  • CRC
  • Scottsdale, Arizona
  • +10 more
Dec 11, 2020

Renal Cell Carcinoma Trial in Australia, Korea, Republic of, United States (Pexastimogene Devacirepvec (Pexa-Vec), Cemiplimab)

Active, not recruiting
  • Renal Cell Carcinoma
  • Pexastimogene Devacirepvec (Pexa-Vec)
  • Cemiplimab
  • Irvine, California
  • +17 more
Oct 26, 2022

Colorectal Cancer, Colorectal Carcinoma, Colorectal Adenocarcinoma Trial run by the NCI (Durvalumab, Tremelimumab, Pexa-Vec)

Active, not recruiting
Has Results
  • Colorectal Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023

Post-neurosurgical Respiratory Muscle Dysfunction

Recruiting
  • Diaphragm Issues
  • +2 more
  • Maximum inspiratory/Expiratory manoeuvre for patients can follow the order
  • Beijing, Beijing, China
    Beijing Sanbo Brain Hospital, Capital Medical University
Jul 11, 2023

Hepatocellular Carcinoma (HCC) Trial in Worldwide (Pexastimogene Devacirepvec (Pexa Vec), Sorafenib)

Completed
Has Results
  • Hepatocellular Carcinoma (HCC)
  • Birmingham, Alabama
  • +141 more
Dec 11, 2020

Bradycardia Trial (JX- XFINE lead)

Not yet recruiting
  • Bradycardia
  • JX- XFINE lead
  • (no location specified)
Jun 27, 2022

Immunogenicity of After Primary Immunization and Booster

Active, not recruiting
  • Polio
  • no intervention
  • Pingxiang, Jiangxi, China
    Shangli Center for Disease Control and Prevention
Sep 21, 2023

Patient Adherence, HIV Positive Trial in Los Angeles, San Diego, Torrance (SoC + ALERT Intervention)

Completed
  • Patient Adherence
  • HIV Positive
  • SoC + ALERT Intervention
  • Los Angeles, California
  • +2 more
Dec 8, 2021

HIV Trial in Mwanza, Shinyanga (Loyalty card program at drug shops & supply of HIVST and SRH products, Comparison drug shops)

Recruiting
  • HIV Infections
  • Loyalty card program at drug shops & supply of HIVST and SRH products
  • Comparison drug shops
  • Mwanza, Tanzania
  • +1 more
Aug 22, 2022

MDD, Treatment Resistant Depression Trial in Chicago, Melbourne (Nitrous oxide gas for inhalation, Placebo)

Recruiting
  • Major Depressive Disorder
  • Treatment Resistant Depression
  • Nitrous oxide gas for inhalation
  • Placebo
  • Chicago, Illinois
  • +1 more
Dec 21, 2022

Nasopharyngeal Carcinoma Trial in Guangzhou (CCRT+Nimotuzumab, CCRT alone)

Active, not recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen Universitty Cancer Center
Nov 22, 2021

SARS-CoV-2 Acute Respiratory Disease Trial in São Paulo (Muscle ultrasound evaluation)

Recruiting
  • SARS-CoV-2 Acute Respiratory Disease
  • Muscle ultrasound evaluation
  • São Paulo, Brazil
    Hospital Israelita Albert Einstein
Oct 5, 2021

Following SARS-CoV-2 (Covid-19) Vaccinations

Recruiting
  • Covid-19
  • Subjects Vaccinated Against Covid-19
  • Change in SARS-CoV-2 Antibody Levels
  • Southlake, Texas
    Southlake Diagnostics, Inc.
Aug 26, 2022

Post-COVID-19 Syndrome, Long COVID, Vitamin D Deficiency Trial in Durango (Magnesium chloride, Vitamin D, Inert )

Not yet recruiting
  • Post-COVID-19 Syndrome
  • +3 more
  • Magnesium chloride
  • +2 more
  • Durango, Dgo, Mexico
    Biomedical Research Unit. IMSS. Durango
Dec 26, 2022

Venous Leg Ulcer Trial in Galway (Endovenous ablation + iliac US +/- iliac stenting, Endovenous ablation of Great Saphenous

Recruiting
  • Venous Leg Ulcer
  • Endovenous ablation + iliac US +/- iliac stenting
  • Endovenous ablation of Great Saphenous Vein
  • Galway, Ireland
  • +1 more
Mar 2, 2021

Colorectal Carcinoma Trial in Seoul (JX-594)

Completed
  • Colorectal Carcinoma
  • JX-594
  • Seoul, Korea, Republic of
    Samsung Medical Center
Feb 15, 2017

Dysphoria Trial in Oxford (Transcranial direct current stimulation (tDCS))

Recruiting
  • Dysphoria
  • Transcranial direct current stimulation (tDCS)
  • Oxford, United Kingdom
    FMRIB Centre, John Radcliffe Hospital, University of Oxford
Apr 13, 2021

Metastatic Breast Cancer Trial in France (Eribulin)

Withdrawn
  • Metastatic Breast Cancer
  • Angers, France
  • +6 more
May 5, 2020

Elderly, Epidural Anesthesia, General Anesthesia Trial in Beijing (Combined Epi-GA/PCEA, GA/PCIA)

Completed
  • Elderly
  • +4 more
  • Combined Epi-GA/PCEA
  • GA/PCIA
  • Beijing, China
    Department of Anesthesiology and Critical Care Medicine, Peking
Jul 6, 2020

Obstructive Sleep Apnea in Acute Myocardial Infarction

Completed
  • Obstructive Sleep Apnea
  • Acute Myocardial Infarction
  • WATCH-PAT
  • Wonju, Korea, Republic of
    Wonju Severance Christian Hospital
Oct 9, 2020

Tumors Trial in Pamplona, Madrid (Urelumab + Nivolumab)

Unknown status
  • Neoplasms
  • Urelumab + Nivolumab
  • Pamplona, Navarra, Spain
  • +1 more
Jan 2, 2019

Depression, Impaired Glucose Tolerance Trial run by the NICHD (The Blues Program, Hey Durham)

Completed
  • Depression
  • Impaired Glucose Tolerance
  • The Blues Program
  • Hey Durham
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 13, 2019